We’re honored to be featured in publications near and far, but there’s something especially meaningful about being recognized by our local and regional community. Thank you to Teknovation for helping share the news of our latest opportunity. Be sure to explore more of their excellent coverage here: https://www.teknovation.biz/
“The CE marked tests provide Hepion with the ability to generate near term revenues in European Union countries by leveraging the existing distributor network relationships that New Day Diagnostics has established. We are excited by this opportunity and look forward to working with New Day to maximize value,” said John Brancaccio, Executive Chairman and Interim Chief Executive Officer (CEO) of Hepion.
“This alliance represents a strategic step forward in our mission to bring accessible, high-impact diagnostics to patients around the world,” said Eric Mayer, CEO of New Day Diagnostics. “We’re excited to partner with Hepion to expand the reach of these CE-marked tests, bring them to the United States, and unlock new opportunities to improve early detection and outcomes across multiple disease areas.” Continue reading on TEKNOVATION.